Tag: MichelVounatsos

Biotechnology Healthcare Investing News Market News Technology

Biogen Shares Crater after Scrapping Alzheimer’s Drug

financial buzz03/21/2019

6984

Biogen Inc. (NASDAQ: BIIB) shares cratered on Thursday morning after the Company decided to terminate its Phase 3 and future clinical trials for its Alzheimer’s disease drug. Biogen shares...

Biotechnology Investing News Market News Technology

Biogen Acquires Nightstar for USD 800 Million to Develop Gene Therapy

Bryan Shin03/05/2019

4438

Biogen Inc. (NASDAQ: BIIB) announced on Monday that it has entered into an agreement to acquire Nightstar Therapeutics (NASDAQ: NITE) for an all cash offer of USD 800 Million....

Tag: MichelVounatsos

Biogen Shares Crater after Scrapping Alzheimer’s Drug

Biogen Acquires Nightstar for USD 800 Million to Develop Gene Therapy

ABOUT US

Tweets